Choi Joon Young, Ji Wonjun, Choi Chang-Min, Chung Chaeuk, Noh Jae Myoung, Park Cheol-Kyu, Oh In-Jae, Yoon Hong In, Kim Hyeong Ryul, Kim Ho Young, Yeo Chang Dong, Jang Seung Hun
Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
Department of Pulmonology and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Tuberc Respir Dis (Seoul). 2021 Apr;84(2):105-114. doi: 10.4046/trd.2020.0098. Epub 2020 Dec 8.
Complementary and alternative medicine (CAM) has been used frequently, and its use continues to increase in lung cancer patients, despite insufficient scientific of its efficacy. To investigate this situation, we analyzed the current awareness and use of CAM in Korean lung-cancer patients.
This prospective survey-based study was performed at seven medical centers in South Korea between August and October 2019. The survey assessed general patient characteristics and the awareness and use of CAM. We analyzed differences in the clinical parameters of patients aware and not aware of CAM and of CAM non-users and users.
Of the 434 patients included in this study, 68.8% responded that they were aware of CAM and 30.9% said they had experienced it. In univariate analysis, the patients aware of CAM were younger with poor performance status, had advanced-stage lung cancer, received more systemic therapy, and received concurrent chemoradiation therapy (CCRT). By multiple logistic regression, younger age, poor performance status, advanced stage, and prior CCRT were identified as independent risk factors for CAM awareness. There were no significant differences in the general characteristics and cancer-associated clinical parameters of CAM non-users and users.
Specific clinical parameters were associated with patients' awareness of CAM, although there were no significantly different characteristics between CAM users and non-users.
补充和替代医学(CAM)已被频繁使用,尽管其疗效缺乏充分的科学依据,但肺癌患者对其使用仍在不断增加。为了调查这种情况,我们分析了韩国肺癌患者对CAM的当前认知和使用情况。
这项基于前瞻性调查的研究于2019年8月至10月在韩国的七个医疗中心进行。该调查评估了患者的一般特征以及对CAM的认知和使用情况。我们分析了知晓和不知晓CAM的患者以及CAM非使用者和使用者在临床参数上的差异。
在本研究纳入的434例患者中,68.8%的患者表示知晓CAM,30.9%的患者表示曾使用过。在单因素分析中,知晓CAM的患者年龄较小,体能状态较差,患有晚期肺癌,接受的全身治疗更多,且接受同步放化疗(CCRT)。通过多因素逻辑回归分析,年龄较小、体能状态较差、晚期以及既往接受CCRT被确定为CAM知晓的独立危险因素。CAM非使用者和使用者在一般特征和癌症相关临床参数方面没有显著差异。
特定的临床参数与患者对CAM的知晓有关,尽管CAM使用者和非使用者之间没有显著不同的特征。